Exchange Traded Concepts LLC Makes New $135,000 Investment in DaVita Inc. (NYSE:DVA)

Exchange Traded Concepts LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA) in the third quarter, according to its most recent filing with the SEC. The firm purchased 823 shares of the company’s stock, valued at approximately $135,000.

A number of other large investors have also recently bought and sold shares of the business. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of DaVita by 295.9% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 669 shares of the company’s stock worth $110,000 after purchasing an additional 500 shares in the last quarter. Clarius Group LLC bought a new position in shares of DaVita during the 3rd quarter worth about $208,000. Contravisory Investment Management Inc. boosted its position in shares of DaVita by 3.8% during the 3rd quarter. Contravisory Investment Management Inc. now owns 6,009 shares of the company’s stock worth $985,000 after purchasing an additional 218 shares in the last quarter. Wedmont Private Capital boosted its position in shares of DaVita by 4.4% during the 3rd quarter. Wedmont Private Capital now owns 1,776 shares of the company’s stock worth $280,000 after purchasing an additional 75 shares in the last quarter. Finally, City Holding Co. boosted its position in shares of DaVita by 8.6% during the 3rd quarter. City Holding Co. now owns 4,341 shares of the company’s stock worth $712,000 after purchasing an additional 345 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of NYSE DVA opened at $163.16 on Wednesday. DaVita Inc. has a fifty-two week low of $75.47 and a fifty-two week high of $168.50. The stock has a market cap of $14.31 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 0.93 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The firm’s 50-day simple moving average is $157.10 and its 200 day simple moving average is $144.89.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, topping the consensus estimate of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.15 billion. During the same quarter last year, the firm earned $2.08 EPS. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, research analysts anticipate that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now owns 837,835 shares of the company’s stock, valued at $138,284,666.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Javier Rodriguez sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the sale, the chief executive officer now owns 837,835 shares in the company, valued at $138,284,666.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 173,482 shares of company stock valued at $27,387,069 in the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DVA shares. Bank of America increased their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. UBS Group increased their price objective on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research report on Monday, October 7th. Finally, TD Cowen raised their price target on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $159.00.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.